The major goal of the Neuropathology (NP) Core is to provide researchers with well characterized and preserved brain tissue and diagnostic neuropathology evaluations for Alzheimer's Disease (AD) patients and controls. Provision of such tissue is essential to the overall goal of the ADCC to promote strong scientific investigations of AD. In order to achieve this goal, the NP Core will carry out the following specific tasks: 1. obtain brain tissue from AD and control patients who have undergone multiple annual neuropsychological and neurological evaluations prior to death; 2. preserve the tissue in a variety of ways in order to allow application of the most up-to-date technologies by researchers; 3. apply standard criteria for the diagnosis of AD to these brains in a consistent fashion and provide a thorough neuropathological evaluation; 4. maintain an awareness of controversies and evolving standards in the diagnostic criteria; 3. store brain tissue and neuropathological data in a reliable way allowing rapid retrieval; and 6. encourage use of resources of the NP Core by researchers through tissue and data accessibility and accommodation of special preservation protocols. To improve access to well-studied control tissue, the ADCC has established the Religious Orders Study (ROS) Core. The NP Core has begun to obtain brain tissue (19 cases so far) from study subjects who have undergone careful neurological and neuropsychological follow-up. This tissue is likely to be especially valuable in making rigorous clinical- pathological correlations. The NP Core proposes to provide investigators with tissue from this a stereological quantitation of PHF-tau immunostained neuritic plaques and neurofibrillary tangles in the frontal, temporal, and parietal cortices, hippocampus, and entorhinal cortex of-tissue from the ROS core subjects, with the goals of further characterizing the interface between Alzheimer's disease and aging changes in the brain and evaluating stereologic technology as a potential tool to assist in diagnostic classification of this area.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010161-09S1
Application #
6295559
Study Section
Project Start
1999-08-15
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Rodrigues, Jovita; Capuano, Ana W; Barnes, Lisa L et al. (2018) Effect of Antidepressant Medication Use and Social Engagement on the Level of Depressive Symptoms in Community-Dwelling, Older African Americans and Whites With Dementia. J Aging Health :898264318772983
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Ahmad, Faraz; Das, Debajyoti; Kommaddi, Reddy Peera et al. (2018) Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep 8:13119
Wilson, Robert S; Barnes, Lisa L; Rajan, Kumar B et al. (2018) Antecedents and consequences of unawareness of memory impairment in dementia. Neuropsychology 32:931-940
Arvanitakis, Zoe; Capuano, Ana W; Bennett, David A et al. (2018) Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci 73:198-203
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Tasaki, Shinya; Gaiteri, Chris; Mostafavi, Sara et al. (2018) The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia. Front Neurosci 12:699
Guo, Caiwei; Jeong, Hyun-Hwan; Hsieh, Yi-Chen et al. (2018) Tau Activates Transposable Elements in Alzheimer's Disease. Cell Rep 23:2874-2880

Showing the most recent 10 out of 786 publications